I'm not a fan of blind faith either, but personally I think some of you are giving Mason too much credit.
His post reeks of somebody who has been doing a lot of searching to try and find something to complain about.
But to try question why Imugene has expanded it's pipeline with a treatment that compliments one of our existing products and is showing incredible pre-clinical data is just crazy.
So given that he is a big believer in a biotech with a single chemotherapy product that could be swept aside by some of imu's products - I don't really think that he is posting for altruistic reasons.
But I could be wrong though.
cheers
Why IMU is a multi multi bagger, page-1656
-
- There are more pages in this discussion • 23,990 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $385.8M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.4¢ | 5.2¢ | $217.9K | 4.100M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 3474945 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 25229 | 9 |
View Market Depth
| Last trade - 11.55am 02/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |